Biktarvy, formally known as bictegravir, represents a powerful single-tablet treatment for managing HIV infection. This drug combines three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the the viral ability to replicate within the body, significantly reducing the viral burden. For many ind